AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionPinnacle Bancorp, Inc.
Latest Disclosed Ownership11,845 shares
Latest Disclosed Value $ 2,576,169
Pinnacle Bancorp, Inc. reports 0.60% decrease in ownership of ABBV / AbbVie Inc.

On April 22, 2026 - Pinnacle Bancorp, Inc. filed a 13F-HR form disclosing ownership of 11,845 shares of AbbVie Inc. (US:ABBV) valued at $2,576,169 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 11,916 shares of AbbVie Inc.. This represents a change in shares of -0.60% during the quarter. The current value of the position is $2,571,905 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F Abbvie Inc Com COM 00287Y109 11,845 -71 -0.60 2,576 -5.36 0.7603
2026-01-22 2025-12-31 13F Abbvie Inc Com COM 00287Y109 11,916 -35 -0.29 2,723 -1.63 0.7980
2025-10-24 2025-09-30 13F Abbvie Inc Com COM 00287Y109 11,951 -167 -1.38 2,767 23.03 0.8173
2025-07-11 2025-06-30 13F Abbvie Inc Com COM 00287Y109 12,118 -356 -2.85 2,249 -13.93 0.6942
2025-04-23 2025-03-31 13F Abbvie Inc Com COM 00287Y109 12,474 -507 -3.91 2,614 13.31 0.8521
2025-01-14 2024-12-31 13F Abbvie Inc Com COM 00287Y109 12,981 -115 -0.88 2,307 -10.83 0.7502
2024-10-09 2024-09-30 13F Abbvie Inc Com COM 00287Y109 13,096 -68 -0.52 2,586 14.58 0.6914
2024-07-15 2024-06-30 13F Abbvie Inc Com COM 00287Y109 13,164 -708 -5.10 2,258 -10.65 0.6667
2024-04-16 2024-03-31 13F Abbvie Inc Com COM 00287Y109 13,872 0 0.00 2,526 17.54 0.7471
2024-01-25 2023-12-31 13F Abbvie Inc Com COM 00287Y109 13,872 -480 -3.34 2,150 0.47 0.7037
2023-10-18 2023-09-30 13F Abbvie Inc Com COM 00287Y109 14,352 -30 -0.21 2,139 10.43 0.7604
2023-07-14 2023-06-30 13F Abbvie Inc Com COM 00287Y109 14,382 462 3.32 1,938 -12.67 0.6625
2023-04-14 2023-03-31 13F Abbvie Inc Com COM 00287Y109 13,920 234 1.71 2,218 110,800.00 0.8143
2023-01-24 2022-12-31 13F Abbvie Inc Com COM 00287Y109 13,686 -853 -5.87 2 -99.90 0.8509
2022-10-25 2022-09-30 13F Abbvie Inc Com COM 00287Y109 14,539 161 1.12 1,951 -11.40 0.8425
2022-07-12 2022-06-30 13F Abbvie Inc Com COM 00287Y109 14,378 -656 -4.36 2,202 -9.64 0.9061
2022-04-14 2022-03-31 13F Abbvie Inc Com COM 00287Y109 15,034 364 2.48 2,437 22.71 0.8455
2022-01-19 2021-12-31 13F Abbvie Inc Com COM 00287Y109 14,670 92 0.63 1,986 26.26 0.7020
2021-10-12 2021-09-30 13F Abbvie Inc Com COM 00287Y109 14,578 869 6.34 1,573 1.88 0.6289
2021-07-15 2021-06-30 13F Abbvie Inc Com COM 00287Y109 13,709 90 0.66 1,544 4.75 0.7045
2021-04-26 2021-03-31 13F Abbvie Inc Com COM 00287Y109 13,619 203 1.51 1,474 2.50 0.7142
2021-01-13 2020-12-31 13F Abbvie Inc Com COM 00287Y109 13,416 -210 -1.54 1,438 20.44 0.8857
2020-10-13 2020-09-30 13F Abbvie Inc Com COM 00287Y109 13,626 -63 -0.46 1,194 -11.16 0.8416
2020-07-07 2020-06-30 13F Abbvie Inc Com COM 00287Y109 13,689 0 0.00 1,344 28.86 0.9997
2020-04-09 2020-03-31 13F Abbvie Inc Com COM 00287Y109 13,689 750 5.80 1,043 -8.99 0.8910
2020-01-10 2019-12-31 13F Abbvie Inc Com COM 00287Y109 12,939 92 0.72 1,146 17.78 0.7941
2019-10-08 2019-09-30 13F Abbvie Inc Com COM 00287Y109 12,847 200 1.58 973 5.76 0.5554
2019-07-08 2019-06-30 13F Abbvie Inc Com COM 00287Y109 12,647 63 0.50 920 -9.27 0.5171
2019-04-05 2019-03-31 13F Abbvie Inc Com COM 00287Y109 12,584 -265 -2.06 1,014 -14.43 0.5881
2019-03-20 2018-12-31 13F Abbvie Inc Com COM 00287Y109 12,849 -1,248 -8.85 1,185 28.94 0.7289
2017-04-17 2017-03-31 13F Abbvie Inc Com COM 00287Y109 14,097 14,097 919 0.6498
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.